Bone Loss Not Yet Recruiting Phase 1 / 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04279392Healthy Body, Healthy Bones After Bariatric Surgery TrialPrevention